Philip Bardin

Professor

PROFESSOR, Medicine Monash Health

https://orcid.org/0000-0002-9596-574X

EmailPhilip.Bardin@monash.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Currently he is also Director, Lung & Sleep Medicine, Monash University and Medical Centre, Melbourne.

He is recognised for investigation of obstructive lung diseases (particularly virusasthma-COPD exacerbations) and has conducted extensive research of new asthma and COPD therapies. Recently research has examined vocal cord dysfunction in obstructive lung diseases. Professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD.

He is a recipient of ongoing Australian NH&MRC funding, has chaired the Australian NH&MRC Grant Review Panel (Respiratory & Sleep Medicine) and served on the Australian NH&MRC Academy. Currently he is Co-Editor of Respirology, official journal of the TSANZ and APSR.

Education/Academic qualification

Medicine, FRACP, Royal Australasian College of Physicians

Award Date: 1 Jan 2003

PhD, University of Southampton

Award Date: 1 Jan 1994

Medicine, FCPSA, College of Medicine

Award Date: 1 Jan 1985

External positions

Co-Editor in Chief, Respirology

1 Jan 2017 → …

Director Monash Lung and Sleep, Monash Health

1 Mar 2012 → …

Research area keywords

COPD
Asthma
Laryngeal dysfunction
immunology
Inflammation
exacerbation
bacterial respiratory disease
virus pathogenesis

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

1 Not started
6 Active
12 Finished

A multi-center, randomized, double-blind, parallel-group, placebo-controlled study of mepolizumab 100 mg SC as add-on treatment in participants with COPD experiencing frequent exacerbations and characterized by eosinophil levels (Study 208657)
Bardin, P.
9/01/20 → 8/01/25
Project: Research
Free fatty acid receptors as novel bronchodilator targets in severe asthma
Bourke, J., Dubsky, S., Royce, S., Westall, G., Grainge, C., Oliver, B. G., Ulven, T. & Bardin, P.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/20 → 31/12/22
Project: Research
A 24-week multi-center, double-blind, placebo controlled dose-range finding study to investigate the efficacy and safety of oral QBW251 in COPD patients on triple inhaled therapy (LABA/LAMA/ICS)
Bardin, P.
29/10/19 → 28/10/24
Project: Research
Simultaneously targeting airway contraction and fibrosis as a new therapeutic strategy for asthma
Bourke, J., Royce, S., Bardin, P., Westall, G., Grainge, C., Oliver, B. G., Samuel, C. & Wadsworth, S.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/21
Project: Research
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-Of-Concept (Poc) Study to Assess the Efficacy, Safety and Tolerability of SAR440340, In Patients With Moderate-To-Severe Chronic Obstructive Pulmonary Disease (COPD)
Bardin, P.
17/10/18 → 16/10/23
Project: Research

108 Article
18 Letter
15 Review Article
7 Editorial
More

Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia
Hew, M., McDonald, V. M., Bardin, P. G., Chung, L. P., Farah, C. S., Barnard, A., Cooper, M. S., Gibson, P. G. & Upham, J. W., Oct 2020, In : Medical Journal of Australia. 213, 7, p. 316-320 5 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

1 Citation (Scopus)
Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma
Nair, P., Bardin, P., Humbert, M., Murphy, K. R., Hickey, L., Garin, M., Vanlandingham, R. & Chanez, P., Feb 2020, In : The Journal of Allergy and Clinical Immunology: In Practice. 8, 2, p. 555-564 10 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

10 Citations (Scopus)
Inspiratory vocal cord closure in chronic obstructive pulmonary disease
Leong, P., Ruane, L. E., Phyland, D., Koh, J., MacDonald, M. I., Baxter, M., Lau, K. K., Hamza, K. & Bardin, P. G., 1 Apr 2020, In : European Respiratory Journal. 55, 4, 3 p., 1901466.
Research output: Contribution to journal › Letter › Other › peer-review

1 Citation (Scopus)
Mepolizumab effectiveness and identification of super-responders in severe asthma
Harvey, E. S., Langton, D., Katelaris, C., Stevens, S., Farah, C. S., Gillman, A., Harrington, J., Hew, M., Kritikos, V., Radhakrishna, N., Bardin, P., Peters, M., Reynolds, P. N., Upham, J. W., Baraket, M., Bowler, S., Bowden, J., Chien, J., Chung, L. P., Grainge, C. & 8 others, Jenkins, C., Katsoulotos, G. P., Lee, J., McDonald, V. M., Reddel, H. K., Rimmer, J., Wark, P. A. B. & Gibson, P. G., 1 May 2020, In : The European respiratory journal. 55, 5, 13 p., 1902420.
Research output: Contribution to journal › Article › Research › peer-review

12 Citations (Scopus)
Pirfenidone: Molecular mechanisms and potential clinical applications in lung disease
Ruwanpura, S. M., Thomas, B. J. & Bardin, P. G., 1 Jan 2020, In : American Journal of Respiratory Cell and Molecular Biology. 62, 4, p. 413-422 10 p.
Research output: Contribution to journal › Review Article › Research › peer-review

4 Citations (Scopus)